z-logo
open-access-imgOpen Access
ULTRA-DILUTED VISCUM ALBUM IN THE TREATMENT OF CUTANEOUS MELANOMA IN A DOG (CANIS FAMILIARIS) - CASE REPORT
Author(s) -
Ana Catarina Viana Valle,
Adriana Oliveira Carvalho
Publication year - 2021
Publication title -
paripex indian journal of research
Language(s) - English
DOI - 10.36106/paripex/2308743
Subject(s) - medicine , viscum album , melanoma , surgery , lesion , dermatology , traditional medicine , cancer research
Background: Cutaneous melanoma is one of the tumors with the highest incidence in middle-aged dogs. Effectivesystemic treatments for advanced malignant melanoma are lacking, and survival is about 1 to 3 months. Viscum albumtherapy is among the complementary therapies against cancer. A 7-year-old Dogue de Bordeaux female d Methods: og.The main complaint was an ulcerated lesion in the right anterior leg. The animal had already been diagnosed withmalignant cutaneous melanoma 11 months before. Extensive ulcerated lesions in the fourth digit of the right anterior leg,mandibular region, and labial commissures were observed for more than nine months, with no resolution of the initialcondition. Pulmonary metastasis in the left caudal lobe, two evolving breast tumors, and several blackish nodular lesionsspread through the abdomen, lower eyelids, and auricular pavilions were already diagnosed. An injectable,-3 homeopathic treatment was prescribed and consisted of an intravenous application of Viscum album D3 (1x10 ) and-3 -6 auto-hemotherapy, once a week. At home, the tutor performed applications of Viscum album D3 (1x10 ), D6 (1x10 ), D12-12 -30 (1x10 ), D30 (1x10 ), in combinations, SID, subcutaneously, three times a week. The protocol administ Conclusion: eredto the patient in this study was successful in its purpose. It healed the wounds and improved the patient's quality of life.Other studies must be conducted, under the same conditions, to better elucidate the results obtained in the presentstudy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here